Shaotong Zhang

Shaotong Zhang

Auto-generated profile, based on publicly available information

Shaotong Zhang

Department of Clinical Biochemistry, Faculty of Pharmacy and Laboratory Medicine, Army Medical University, Chongqing, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
DNDun Niu
Dun Niu
SZShaotong Zhang
Shaotong Zhang
XMXiaozhuang Ma
Xiaozhuang Ma
YWYaran Wu
Yaran Wu
JZJunshi Zhu
Junshi Zhu
JLJiqin Lian
Jiqin Lian
Gene-directed enzyme prodrug therapy represents a promising antitumor strategy owing to its low systemic toxicity. However, clinical translation has been hindered by challenges in suicide gene delivery. Artificially engineered circular RNA (circRNA) demonstrates exceptional potential for gene delivery when combined with lipid nanoparticle technology, exhibiting high stability, prolonged protein-coding capacity, and cost-effective production. We developed an in vitro synthesized circRNA encoding the cytosine deaminase–uracil phosphoribosyltransferase (circCDUPRT). Upon intratumoral administration, circCDUPRT achieved sustained intratumoral expression with minimal systemic toxicity. The combination of circCDUPRT and prodrug 5-fluorocytosine showed significant antitumor efficacy in both in vitro and in vivo tumor models. In advanced melanoma models, combining circCDUPRT/5-fluorocytosine with IL-15–expressing circRNA potently enhanced the expansion and activation of CD8+ T and NK cells. Collectively, these findings establish the synthetic circRNA platform as a cost-effective, high-efficiency delivery system for gene-directed enzyme prodrug therapy and immunotherapy applications.

4 February 2026
Verified
Other
Open access
DNDun Niu
Dun Niu
SZShaotong Zhang
Shaotong Zhang
XMXiaozhuang Ma
Xiaozhuang Ma
YWYaran Wu
Yaran Wu
JZJunshi Zhu
Junshi Zhu
JLJiqin Lian
Jiqin Lian
Comparison of the CDUPRT distribution, anti-tumor capacity and toxicity of mCDUPRT versus circCDUPRT after intravenous or intratumoral administration.

4 February 2026
Verified
Other
Open access
DNDun Niu
Dun Niu
SZShaotong Zhang
Shaotong Zhang
XMXiaozhuang Ma
Xiaozhuang Ma
YWYaran Wu
Yaran Wu
JZJunshi Zhu
Junshi Zhu
JLJiqin Lian
Jiqin Lian
Gene-directed enzyme prodrug therapy represents a promising antitumor strategy owing to its low systemic toxicity. However, clinical translation has been hindered by challenges in suicide gene delivery. Artificially engineered circular RNA (circRNA) demonstrates exceptional potential for gene delivery when combined with lipid nanoparticle technology, exhibiting high stability, prolonged protein-coding capacity, and cost-effective production. We developed an in vitro synthesized circRNA encoding the cytosine deaminase–uracil phosphoribosyltransferase (circCDUPRT). Upon intratumoral administration, circCDUPRT achieved sustained intratumoral expression with minimal systemic toxicity. The combination of circCDUPRT and prodrug 5-fluorocytosine showed significant antitumor efficacy in both in vitro and in vivo tumor models. In advanced melanoma models, combining circCDUPRT/5-fluorocytosine with IL-15–expressing circRNA potently enhanced the expansion and activation of CD8+ T and NK cells. Collectively, these findings establish the synthetic circRNA platform as a cost-effective, high-efficiency delivery system for gene-directed enzyme prodrug therapy and immunotherapy applications.

4 February 2026
Verified
Other
Open access
DNDun Niu
Dun Niu
SZShaotong Zhang
Shaotong Zhang
XMXiaozhuang Ma
Xiaozhuang Ma
YWYaran Wu
Yaran Wu
JZJunshi Zhu
Junshi Zhu
JLJiqin Lian
Jiqin Lian
Validation of the tumor-targeting capacity and low toxicity of circCDUPRT on a 4T1 tumor-bearing mouse model.

4 February 2026
Verified
Other
Open access
DNDun Niu
Dun Niu
SZShaotong Zhang
Shaotong Zhang
XMXiaozhuang Ma
Xiaozhuang Ma
YWYaran Wu
Yaran Wu
JZJunshi Zhu
Junshi Zhu
JLJiqin Lian
Jiqin Lian
Comparison of mCDUPRT and circCDUPRT in vitro anti-tumor ability, protein translation ability and prodrug transformation ability under different concentrations and times.